Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Conte

Showing results (51-60 of 200) with videos related to

Pageof 20
Sort By:
Cancer Treatment Reports|December 1, 1986
Idarubicin in advanced breast cancer: a phase II studyR Lionetto, P Pronzato, P F Conte, et al.
Epidemiologia E Prevenzione|February 24, 2001
[Experimentation with Di Bella polychemotherapy in Tuscany]C Orlandini, G Amunni, P F Conte, et al.
Biochemical Pharmacology|October 5, 1993
Potentiation of TNF-mediated cell killing by mitoxantrone. Relationship to DNA single-strand break formationM Valenti, G Cimoli, G L Mariani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancerS Fogli, R Danesi, A Gennari, et al.
Pharmacological Research|September 1, 1990
Diethylstilbestrol (DES) and recombinant human growth hormone (rhGH) as modulators of breast cancer proliferative activityA Alama, F Barbieri, G Gardin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: a phase II studyA Michelotti, A Gennari, B Salvadori, et al.
Gynecologic Oncology|June 1, 1997
Significance of lymph node sampling in epithelial carcinoma of the ovaryF Carnino, G Fuda, G Ciccone, et al.
American Journal of Clinical Oncology|October 1, 1987
A phase II study with danazol in metastatic breast cancerP Pronzato, D Amoroso, A Ardizzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotideS Ricci, A Antonuzzo, L Galli, et al.
Tumori|August 31, 1988
Cisplatin and 5-fluorouracil in advanced and recurrent cervical cancerS Chiara, R Consoli, A Falcone, et al.
Pageof 20

Showing results (51-60 of 200) with videos related to

Sort By:
Pageof 20
Cancer Treatment Reports|December 1, 1986
Idarubicin in advanced breast cancer: a phase II studyR Lionetto, P Pronzato, P F Conte, et al.
Epidemiologia E Prevenzione|February 24, 2001
[Experimentation with Di Bella polychemotherapy in Tuscany]C Orlandini, G Amunni, P F Conte, et al.
Biochemical Pharmacology|October 5, 1993
Potentiation of TNF-mediated cell killing by mitoxantrone. Relationship to DNA single-strand break formationM Valenti, G Cimoli, G L Mariani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancerS Fogli, R Danesi, A Gennari, et al.
Pharmacological Research|September 1, 1990
Diethylstilbestrol (DES) and recombinant human growth hormone (rhGH) as modulators of breast cancer proliferative activityA Alama, F Barbieri, G Gardin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: a phase II studyA Michelotti, A Gennari, B Salvadori, et al.
Gynecologic Oncology|June 1, 1997
Significance of lymph node sampling in epithelial carcinoma of the ovaryF Carnino, G Fuda, G Ciccone, et al.
American Journal of Clinical Oncology|October 1, 1987
A phase II study with danazol in metastatic breast cancerP Pronzato, D Amoroso, A Ardizzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotideS Ricci, A Antonuzzo, L Galli, et al.
Tumori|August 31, 1988
Cisplatin and 5-fluorouracil in advanced and recurrent cervical cancerS Chiara, R Consoli, A Falcone, et al.
Pageof 20